Previous Bladder Cancer History in Patients with High-Risk, Non–muscle-invasive Bladder Cancer Correlates with Recurrence and Progression: Implications of Natural History
Lampros P. Mitrakas, Ioannis V. Zachos, Vassileios P. Tzortzis, Stavros A. Gravas, Erasmia C. Rouka, Konstantinos I. Dimitropoulos, Gerasimos P. Vandoros, Anastasios D. Karatzas, Michael D. Melekos, Athanasios G. Papavassiliou
Cancer Res Treat. 2015;47(3):495-500.   Published online 2014 Sep 11     DOI:
Citations to this article as recorded by Crossref logo
Treatment Outcomes of High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIBC) in Real-World Evidence (RWE) Studies: Systematic Literature Review (SLR)
Mihaela Georgiana Musat, Christina Soeun Kwon, Elizabeth Masters, Slaven Sikirica, Debduth B Pijush, Anna Forsythe
ClinicoEconomics and Outcomes Research.2022; Volume 14: 35.     CrossRef
Quality of Life and Anxiety in Patients with First Diagnosed Non-Muscle Invasive Bladder Cancer Who Receive Adjuvant Bladder Therapy
Alexandros Vaioulis, Konstantinos Bonotis, Konstantinos Perivoliotis, Yiannis Kiouvrekis, Stavros Gravas, Vasilios Tzortzis, Anastasios Karatzas
Bladder Cancer.2021; 7(3): 297.     CrossRef
Extensive rhabdomyosarcomatous differentiation in recurrent low-grade urothelial carcinoma of the bladder after transurethral resection: a case report
Maiko Kamei, Tsutomu Shinohara, Kotaro Kasahara, Takahira Kuno, Keishi Naruse, Hironobu Watanabe
Journal of Medical Case Reports.2015;[Epub]     CrossRef